This is a rare genetic condition that affects how your body processes bilirubin, a yellow substance made when your liver breaks down old red blood cells. It causes a buildup of bilirubin, making your skin and eyes look yellow. It's inherited, meaning you get it from your parents. It can cause serious problems if not treated, like brain damage.
Every report comes from a Lived member, sent anonymously.
Have you tried Light Therapy for Crigler-Najjar Syndrome?
Crigler-Najjar syndrome is a rare inherited condition in which the liver cannot properly clear bilirubin, a yellow-orange substance made when old red blood cells are broken down. Normally a liver enzyme attaches a sugar-like molecule to bilirubin so it dissolves in water and leaves the body in bile. Without enough of that enzyme, bilirubin builds up in the blood, turning the skin and the whites of the eyes yellow (jaundice) from birth or early infancy. The jaundice itself is not the main danger. At very high levels, bilirubin can pass into the brain and cause lasting damage called kernicterus, which can lead to movement problems, hearing loss, intellectual disability and, without treatment, death. There are two types. In type 1, the enzyme does not work at all, bilirubin stays very high for life, and daily treatment is needed from the first days of life. In type 2 (sometimes called Arias syndrome), a small amount of enzyme activity remains, bilirubin runs lower, and most people reach adulthood without brain damage, although they can still be at risk when bilirubin spikes. Fewer than 1 in a million newborns are affected.
Crigler-Najjar syndrome is caused by changes in the UGT1A1 gene, which carries the instructions for the bilirubin-clearing enzyme. It is inherited in an autosomal recessive pattern: a child is affected only when both copies of the gene, one from each parent, carry a change. Parents who each carry one changed copy are usually healthy, and each of their children has a one-in-four chance of being affected. The condition is more common in families where parents are related by blood and in some close-knit communities, including Old Order Amish and Mennonite populations. A milder change in the same gene causes Gilbert syndrome, a common and harmless condition in which bilirubin rises only slightly. The two are related but should not be confused. Although nothing a person does causes Crigler-Najjar syndrome, certain situations can push bilirubin higher in someone who has it. Infections and other illnesses, breaks in light treatment, surgery and blockage of the bile ducts are the main ones, and they are the reason planning ahead matters so much.
The condition is usually suspected in a newborn whose jaundice is severe and does not fade the way ordinary newborn jaundice does. Blood tests show a high level of unconjugated bilirubin (the form the liver has not yet processed), while tests for faster-than-normal breakdown of red blood cells and for other liver problems come back normal. Doctors first rule out more common causes of newborn jaundice. Bilirubin is measured in milligrams per deciliter (mg/dL). Yellowing usually becomes visible above about 5. In type 1, levels are typically above 20 and can reach 50. In type 2, they usually fall between about 3.5 and 20, though illness can push them higher. By comparison, people with Gilbert syndrome rarely go above about 4. Levels in the two types can overlap, especially during a flare. Genetic testing of the UGT1A1 gene confirms the diagnosis. A trial of phenobarbital also helps tell the types apart: it lowers bilirubin by roughly a quarter in type 2 but has little or no effect in type 1. Because the two types are managed so differently, getting this distinction right is one of the most important early steps.
Treatment aims to keep bilirubin low enough to protect the brain, and the approach depends on the type. For type 1, the mainstay is phototherapy: blue light shone on bare skin changes bilirubin into forms the body can excrete without the missing enzyme. Most people need whole-body treatment for about 10 to 12 hours a day, usually overnight, starting at birth. It works well in babies and young children but becomes less effective around puberty as skin thickens and the body grows larger relative to its skin surface, so bilirubin can climb in the teenage years. For type 2, phenobarbital, a long-used barbiturate medicine also used for seizures, can prompt the liver to make more of the partly working enzyme and lowers bilirubin for many people. Some need it only during illness or stress, others take it every day, and a few need shorter phototherapy sessions too. Phenobarbital does not help type 1. Liver transplant is the only treatment that cures type 1, because the new liver makes the enzyme. Survival after transplant is high, with reported rates of roughly 80 to 90 percent at 10 years. The trade-offs are major surgery, limited donor availability and lifelong medicines to prevent rejection, which raise the risk of infections and some cancers. Timing is a careful judgment: waiting too long risks brain damage, while very early transplant adds surgical and immune-suppression risk. A partial liver from a living relative is one option. During a dangerous bilirubin rise, hospitals may add intensive phototherapy, albumin given through a vein (albumin is a blood protein that binds bilirubin) and plasma exchange, which filters bilirubin out of the blood. These are short-term rescue measures, as bilirubin climbs again afterward. Gene therapy, which delivers a working copy of the gene to the liver, is being tested in clinical trials. In an early study, three patients who received the higher dose were able to stop phototherapy for well over a year, but it is not yet a standard treatment.
With consistent treatment, many people with type 1 grow up without brain damage, but daily life is shaped by the light therapy. Long overnight sessions at home make travel, sleepovers and spontaneous plans harder, and families carry a large share of the work in the early years. Regular blood tests track bilirubin and guide how many hours of light are needed, and most people are followed by a specialist liver or metabolic team. As childhood ends and light therapy loses strength, the question of liver transplant usually becomes more pressing. Type 2 is usually much milder. Many people live with visible jaundice and few other problems, taking phenobarbital daily or only when needed. The main thing to plan around is that bilirubin can rise sharply during infection or other illness, surgery or other physical stress, at any age. Risk of brain injury does not end with infancy: bilirubin-related nerve damage has occurred in teenagers and adults during flares. Before any surgery or hospital stay, the treating team needs a plan for keeping bilirubin down, including how light therapy will continue. Pregnancy also needs early specialist planning, because bilirubin crosses the placenta and can harm the baby's brain; bilirubin is monitored closely and treatment adjusted throughout. Because the condition is inherited, genetic counseling can help relatives understand their chances of being carriers and the options for future pregnancies.
See a doctor if a newborn's jaundice is deep, spreading or not fading as expected, or if an older child or adult has unexplained lifelong yellowing of the skin or eyes. Anyone with Crigler-Najjar syndrome should also have a specialist review well before planned surgery, pregnancy or a change in treatment. Contact the care team the same day for fever or another infection, vomiting or being unable to keep food or medicine down, jaundice that looks deeper than usual, or a light-therapy unit that breaks or cannot be used, since these are the situations in which dangerous bilirubin rises usually start. Get emergency care right away for signs that bilirubin may be affecting the brain: unusual sleepiness or difficulty waking, confusion or slurred speech, new clumsiness, unsteadiness or abnormal movements, or, in a baby, floppiness, stiffness or back arching. Tell the emergency team about the diagnosis, as prompt treatment can prevent permanent damage.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Crigler-Najjar Syndrome is like, what's helped you, or ask the community a question.